Jeff Boerneke serves as General Counsel and Secretary at Aspen Neuroscience, where he leads the company’s legal strategy and oversees corporate governance, compliance, and transactional matters in support of Aspen’s continued growth and advancement toward Phase 3 development.
Jeff previously served as Senior Vice President, General Counsel and Secretary at Gossamer Bio, where he was a member of the executive team and led all legal functions, including corporate governance, public company reporting, financings, partnerships, intellectual property, and clinical and commercial contracting. He also played a key role in the company’s initial public offering and strategic global partnership activities.
Earlier in his career, Jeff held roles at Amgen, supporting corporate finance, governance, and global operations, and was a corporate associate at Latham & Watkins LLP, where he advised on capital markets transactions, mergers and acquisitions, and licensing agreements.
Jeff holds a J.D. from UCLA School of Law and a B.S. in Chemistry from Point Loma Nazarene University.